The health crisis due to coronavirus disease 2019 (COVID-19) has shocked the world, with more than 1 million infections and casualties. COVID-19 can present from mild illness to multi-organ involvement, but especially acute respiratory distress syndrome. Cardiac injury and arrhythmias, including atrial fibrillation (AF), are not uncommon in COVID-19. COVID-19 is highly contagious, and therapy against the virus remains premature and largely unknown, which makes the management of AF patients during the pandemic particularly challenging. We describe a possible pathophysiological link between COVID-19 and AF, and therapeutic considerations for AF patients during this pandemic.
CITATION STYLE
Hu, Y. F., Cheng, W. H., Hung, Y., Lin, W. Y., Chao, T. F., Liao, J. N., … Chen, S. A. (2020, September 25). Management of atrial fibrillation in COVID-19 pandemic. Circulation Journal. Japanese Circulation Society. https://doi.org/10.1253/circj.CJ-20-0566
Mendeley helps you to discover research relevant for your work.